{"id":164148,"date":"2024-08-29T07:09:43","date_gmt":"2024-08-29T11:09:43","guid":{"rendered":"https:\/\/44.250.171.167\/?p=164148"},"modified":"2024-08-29T07:09:44","modified_gmt":"2024-08-29T11:09:44","slug":"wanbury-ltd-q4fy24-3197-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/wanbury-ltd-q4fy24-3197-rise-in-profits\/","title":{"rendered":"Wanbury Ltd Q4FY24; 3197% rise in Profits"},"content":{"rendered":"\n<p>Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research<\/p>\n\n\n\n<p style=\"font-size:24px\"><strong>Financial Results:<\/strong><\/p>\n\n\n\n<p>Wanbury Ltd reported Revenues for Q4FY24 of \u20b9139.41 Crores up from \u20b9132.98 Crore year on year, a rise of 4.84%.<\/p>\n\n\n\n<p>Total Expenses for Q4FY24 of \u20b9131.98 Crores up from \u20b9129.41 Crores year on year, a rise of 1.99%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b933.63 Crores up 3197.06% from \u20b91.02 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b910.27, up 3,212.90% from \u20b90.31 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190-839x1024.png\" alt=\"\" class=\"wp-image-164149\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research Financial Results: Wanbury Ltd reported Revenues for Q4FY24 of \u20b9139.41 Crores up from \u20b9132.98 Crore year on year, a rise of 4.84%. Total Expenses for Q4FY24 of \u20b9131.98 Crores up from \u20b9129.41 Crores year on year, a rise of [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":164149,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-164148","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-190.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":162460,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q4fy24-31-rise-in-profits\/","url_meta":{"origin":164148,"position":0},"title":"ERIS Lifesciences Ltd Q4FY24; 31% rise in Profits","author":"Divyansh_Kasana","date":"June 24, 2024","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q4FY24 of \u20b9551.00 Crores up from \u20b9403.00 Crore year on year, a rise of 36.72%. Total Expenses for Q4FY24 of \u20b9489.00 Crores up from \u20b9328.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162020,"url":"https:\/\/alphastreet.com\/india\/alkem-laboratories-ltd-q4fy24-347-rise-in-profits\/","url_meta":{"origin":164148,"position":1},"title":"Alkem Laboratories Ltd Q4FY24; 347% rise in Profits","author":"Divyansh_Kasana","date":"June 7, 2024","format":false,"excerpt":"Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. Financial Results: Alkem Laboratories Ltd reported Revenues for Q4FY24 of \u20b92,936.00 Crores up from \u20b92,903.00 Crore year on year, a rise of 1.14%. Total Expenses\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-84.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161623,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q4fy24-56-rise-in-profits\/","url_meta":{"origin":164148,"position":2},"title":"Torrent Pharmaceuticals Ltd Q4FY24; 56% rise in Profits","author":"Chirag Gupta","date":"May 25, 2024","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q4FY24 of \u20b92,745.00 Crores up from \u20b92,491.00 Crore year on year, a rise of 10.2%. Total Expenses for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-197.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162090,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q4fy24-79-rise-in-profits\/","url_meta":{"origin":164148,"position":3},"title":"Aurobindo Pharma Ltd Q4FY24; 79% rise in Profits","author":"Divyansh_Kasana","date":"June 11, 2024","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159) Financial Results: Aurobindo Pharma Ltd reported Revenues for Q4FY24 of \u20b97,580.00 Crores up from \u20b96,473.00 Crore year on year, a rise of 17.1%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-105.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161111,"url":"https:\/\/alphastreet.com\/india\/dr-reddys-laboratories-ltd-q4fy24-54-rise-in-profits\/","url_meta":{"origin":164148,"position":4},"title":"Dr Reddy&#8217;s Laboratories Ltd Q4FY24; 54% rise in Profits","author":"Divyansh_Kasana","date":"May 14, 2024","format":false,"excerpt":"Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddy's Laboratories Ltd reported Revenues for Q4FY24 of \u20b95,105.00 Crores up from \u20b94,554.00 Crore year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-94.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":160884,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q4fy24-39-rise-in-profits\/","url_meta":{"origin":164148,"position":5},"title":"Ajanta Pharma Ltd Q4FY24; 39% rise in Profits","author":"Divyansh_Kasana","date":"May 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q4FY24 of \u20b9926.00 Crores up from \u20b9849.00 Crore year on year, a rise of 9.07%. Total Expenses for Q4FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-40.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=164148"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164148\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/164149"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=164148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=164148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=164148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}